AUG 01, 2017

China presents a huge market for many New Zealand industries, but medical technology (MedTech) has the chance to be among the most successful. China offers New Zealand MedTech companies more than 1 billion possible consumers, along with opportunities for collaboration and investment from Chinese medical firms. Beyond Capital has recognised this potential and formed a partnership with the Consortium for Medical Device Technologies (CMDT).

The CMDT is a single point of contact for New Zealand’s national industry research network. It is a national industry research network between Callaghan innovation and five New Zealand universities: Auckland University, AUT, Victoria University, Canterbury University and Otago University. Beyond Capital is helping the New Zealand researchers to connect to Chinese medical professionals and access the clinical trials network in China